DENVER, April 1, 2026 /PRNewswire/ -- Mary's Medicinals, a subsidiary of MM Brands Inc. (MM Brands), officially announced today its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid therapy trial program. Launched today under the CMS...
Hence then, the article about mary s medicinals announces its intention to participate in the newly announced medicare and medicaid cms trial program with its award winning cannabinoid based wellness products was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Mary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness Products )
Also on site :
- Trump economic approval tanks
- Dodgers Claim Grant Holman From D-Backs
- BTS Dominates YouTube’s Global, U.S. Charts